{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:20:57Z","timestamp":1787019657122,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Studies carried out during the 1990's demonstrated the presence of fungal glycoinositol phosphorylceramides (GIPCs) with unique structures, some of them showed reactivity with sera of patients with histoplasmosis, paracoccidioidomycosis or aspergillosis. It was also observed that fungal GIPCs were able to inhibit T lymphocyte proliferation \"in vitro\", and studies regarding the importance of these molecules to fungal survival showed that many species of fungi are vulnerable to inhibitors of sphingolipid biosynthesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In this paper, we describe a detailed characterization of an IgG2a monoclonal antibody (mAb), termed MEST-3, directed to the\n                      <jats:italic>Paracoccidioides brasiliensis<\/jats:italic>\n                      glycolipid antigen Pb-2 (Man\n                      <jats:italic>p<\/jats:italic>\n                      \u03b11\u21923Man\n                      <jats:italic>p<\/jats:italic>\n                      \u03b11\u21922IPC). mAb MEST-3 also recognizes GIPCs bearing the same structure in other fungi. Studies performed on fungal cultures clearly showed the strong inhibitory activity of MEST-3 on differentiation and colony formation of\n                      <jats:italic>Paracoccidioides brasiliensis<\/jats:italic>\n                      ,\n                      <jats:italic>Histoplasma capsulatum<\/jats:italic>\n                      and\n                      <jats:italic>Sporothrix schenckii<\/jats:italic>\n                      . Similar inhibitory results were observed when these fungi where incubated with a different mAb, which recognizes GIPCs bearing terminal residues of \u03b2-D-galactofuranose linked to mannose (mAb MEST-1). On the other hand, mAb MEST-2 specifically directed to fungal glucosylceramide (GlcCer) was able to promote only a weak inhibition on fungal differentiation and colony formation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results strongly suggest that mAbs directed to specific glycosphingolipids are able to interfere on fungal growth and differentiation. Thus, studies on surface distribution of GIPCs in yeast and mycelium forms of fungi may yield valuable information regarding the relevance of glycosphingolipids in processes of fungal growth, morphological transition and infectivity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/1471-2180-10-47","type":"journal-article","created":{"date-parts":[[2010,2,16]],"date-time":"2010-02-16T02:16:00Z","timestamp":1266286560000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Effect of anti-glycosphingolipid monoclonal antibodies in pathogenic fungal growth and differentiation. Characterization of monoclonal antibody MEST-3 directed to Manp \u03b11\u21923Manp \u03b11\u21922IPC"],"prefix":"10.1186","volume":"10","author":[{"given":"Marcos S","family":"Toledo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loriane","family":"Tagliari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudinei M","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita H","family":"Straus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helio K","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,15]]},"reference":[{"key":"1003_CR1","first-page":"3","volume-title":"Medical Mycology","author":"E Drouhet","year":"1998","unstructured":"Drouhet E: Historical introduction. Medical Mycology. Edited by: Ajello L, Hay R. 1998, Arnold New York, 3-42."},{"key":"1003_CR2","doi-asserted-by":"publisher","first-page":"895","DOI":"10.2174\/138945005774912744","volume":"6","author":"IEJA Fran\u00e7ois","year":"2005","unstructured":"Fran\u00e7ois IEJA, Aerts AM, Cammue BPA, Thevissen K: Currently Used Antimycotics: Spectrum, Mode of Action and Resistance Occurrence. Current Drug Targets. 2005, 6: 895-907. 10.2174\/138945005774912744.","journal-title":"Current Drug Targets"},{"key":"1003_CR3","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.7164\/antibiotics.46.1414","volume":"46","author":"K Takesako","year":"1993","unstructured":"Takesako K, Kuroda H, Inoue T, Haruna F, Yoshikawa Y, Kato I, Uchida K, Hiratani T, Yamaguchi H: Biological properties of aureobasidin A, a cyclic depsipeptide antifungal antibiotic. J Antibiot. 1993, 46: 1414-1420.","journal-title":"J Antibiot"},{"key":"1003_CR4","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1517\/13543784.9.8.1787","volume":"9","author":"NH Georgopapadakou","year":"2000","unstructured":"Georgopapadakou NH: Antifungals targeted to sphingolipid synthesis: focus on inositol phosphorylceramide synthase. Expert Opin Investig Drugs. 2000, 9: 1787-1796. 10.1517\/13543784.9.8.1787.","journal-title":"Expert Opin Investig Drugs"},{"key":"1003_CR5","doi-asserted-by":"publisher","first-page":"9809","DOI":"10.1074\/jbc.272.15.9809","volume":"272","author":"MM Nagiec","year":"1997","unstructured":"Nagiec MM, Nagiec EE, Baltisberger JA, Wells GB, Lester RL, Dickson RC: Sphingolipid synthesis as a target for antifungal drugs. Complementation of the inositol phosphorylceramide synthase defect in a mutant strain of Saccharomyces cerevisiae by the AUR1 gene. J Biol Chem. 1997, 272: 9809-9817. 10.1074\/jbc.272.15.9809.","journal-title":"J Biol Chem"},{"key":"1003_CR6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.bbagen.2007.09.009","volume":"1780","author":"E Suzuki","year":"2008","unstructured":"Suzuki E, Tanaka AK, Toledo MS, Levery SB, Takahashi HK, Straus AH: Trypanosomatid and fungal glycolipids and sphingolipids as infectivity factors and potential targets for development of new therapeutic strategies. Biochim Biophys Acta. 2008, 1780: 362-369.","journal-title":"Biochim Biophys Acta"},{"key":"1003_CR7","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1590\/S0001-37652009000300012","volume":"81","author":"HK Takahashi","year":"2009","unstructured":"Takahashi HK, Toledo MS, Suzuki E, Tagliari L, Straus AH: Current relevance of fungal and trypanosomatid glycolipids and sphingolipids: studies defining structures conspicuously absent in mammals. An Acad Bras Cienc. 2009, 81: 477-488.","journal-title":"An Acad Bras Cienc"},{"key":"1003_CR8","doi-asserted-by":"publisher","first-page":"5581","DOI":"10.1021\/bi00318a031","volume":"23","author":"K Barr","year":"1984","unstructured":"Barr K, Lester RL: Occurrence of novel antigenic phosphoinositol-containing sphingolipids in the pathogenic yeast Histoplasma capsulatum. Biochemistry. 1984, 23: 5581-5588. 10.1021\/bi00318a031.","journal-title":"Biochemistry"},{"key":"1003_CR9","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.1021\/bi00318a032","volume":"23","author":"K Barr","year":"1984","unstructured":"Barr K, Laine RA, Lester RL: Carbohydrate structures of three novel phosphoinositol-containing sphingolipids from the yeast Histoplasma capsulatum. Biochemistry. 1984, 23: 5589-5596. 10.1021\/bi00318a032.","journal-title":"Biochemistry"},{"key":"1003_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/02681219580000501","volume":"33","author":"MS Toledo","year":"1995","unstructured":"Toledo MS, Suzuki E, Straus AH, Takahashi HK: Glycolipids from Paracoccidioides brasiliensis. Isolation of a galactofuranose-containing glycolipid reactive with sera of patients with paracoccidioidomycosis. J Med Vet Mycol. 1995, 33: 247-251. 10.1080\/02681219580000501.","journal-title":"J Med Vet Mycol"},{"key":"1003_CR11","doi-asserted-by":"publisher","first-page":"8764","DOI":"10.1021\/bi9730083","volume":"37","author":"SB Levery","year":"1998","unstructured":"Levery SB, Toledo MS, Straus AH, Takahashi HK: Structure elucidation of sphingolipids from the mycopathogen Paracoccidioides brasiliensis : An immunodominant \u03b2-galactofuranose residue is carried by a novel glycosylinositol phosphorylceramide antigen. Biochemistry. 1998, 37: 8764-8775. 10.1021\/bi9730083.","journal-title":"Biochemistry"},{"key":"1003_CR12","first-page":"919","volume":"28","author":"AH Straus","year":"1995","unstructured":"Straus AH, Suzuki E, Toledo MS, Takizawa C, Takahashi HK: Immunochemical characterization of carbohydrate antigens from fungi, protozoa and mammals by monoclonal antibodies directed to glycan epitopes. Braz J Med Biol Res. 1995, 28: 919-923.","journal-title":"Braz J Med Biol Res"},{"key":"1003_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/glycob\/7.4.463","volume":"7","author":"E Suzuki","year":"1997","unstructured":"Suzuki E, Toledo MS, Takahashi HK, Straus AH: A monoclonal antibody directed to terminal residue of beta-galactofuranose of a glycolipid antigen isolated from Paracoccidioides brasiliensis : cross-reactivity with Leishmania major and Trypanosoma cruzi. Glycobiology. 1997, 7: 463-468. 10.1093\/glycob\/7.4.463.","journal-title":"Glycobiology"},{"key":"1003_CR14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1128\/CVI.00285-06","volume":"14","author":"S Bertini","year":"2007","unstructured":"Bertini S, Colombo AL, Takahashi HK, Straus AH: Expression of antibodies directed to Paracoccidioides brasiliensis glycosphingolipids during the course of paracoccidioidomycosis treatment. Clin Vaccine Immunol. 2007, 14: 150-156. 10.1128\/CVI.00285-06.","journal-title":"Clin Vaccine Immunol"},{"key":"1003_CR15","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1194\/jlr.M700149-JLR200","volume":"48","author":"MS Toledo","year":"2007","unstructured":"Toledo MS, Levery SB, Bennion B, Guimar\u00e3es LL, Castle SA, Lindsey R, Momany M, Park C, Straus AH, Takahashi HK: Analysis of glycosylinositol phosphorylceramides expressed by the opportunistic mycopathogen Aspergillus fumigatus. J Lipid Res. 2007, 48: 1801-1824. 10.1194\/jlr.M700149-JLR200.","journal-title":"J Lipid Res"},{"key":"1003_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1042\/bj20031307","volume":"378","author":"K Aoki","year":"2004","unstructured":"Aoki K, Uchiyama R, Itonori S, Sugita S, Che FS, Isogai A, Hada N, Takeda T, Kumagai H, Yamamoto K: Structural elucidation of novel phosphocholine-containing glycosylinositol-phosphoceramide in filamentous fungi and their induction of cell death of cultured rice cells. Biochem J. 2004, 378: 461-472. 10.1042\/BJ20031307.","journal-title":"Biochem J"},{"key":"1003_CR17","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1194\/jlr.M300184-JLR200","volume":"44","author":"B Bennion","year":"2003","unstructured":"Bennion B, Park C, Fuller M, Lindsey R, Momany M, Jennemann R, Levery SB: Glycosphingolipids of the model fungus Aspergillus nidulans : characterization of GIPCs with oligo-alpha-mannose-type glycans. J Lipid Res. 2003, 44: 2073-2088. 10.1194\/jlr.M300184-JLR200.","journal-title":"J Lipid Res"},{"key":"1003_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/glycob\/cwf053","volume":"12","author":"N Heise","year":"2002","unstructured":"Heise N, Gutierrez ALS, Mattos KA, Jones C, Wait R, Previato JO, Mendon\u00e7a-Previato L: Molecular analysis of a novel family of complex glycoinositolphosphoryl ceramides from Cryptococcus neoformans : Structural differences between encapsulated and acapsular yeast forms. Glycobiology. 2002, 12: 409-420. 10.1093\/glycob\/cwf053.","journal-title":"Glycobiology"},{"key":"1003_CR19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/glycob\/cwm122","volume":"18","author":"C Simenel","year":"2008","unstructured":"Simenel C, Coddeville B, Delepierre M, Latg\u00e9 JP, Fontaine T: Glycosylinositolphosphoceramides in Aspergillus fumigatus. Glycobiology. 2008, 18: 84-96. 10.1093\/glycob\/cwm122.","journal-title":"Glycobiology"},{"key":"1003_CR20","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.1128\/jb.178.21.6223-6226.1996","volume":"178","author":"GB Wells","year":"1996","unstructured":"Wells GB, Dickson RC, Lester RL: Isolation and composition of inositolphosphorylceramide-type sphingolipids of hyphal forms of Candida albicans. J Bacteriol. 1996, 178: 6223-6226.","journal-title":"J Bacteriol"},{"key":"1003_CR21","doi-asserted-by":"publisher","first-page":"7294","DOI":"10.1021\/bi982898z","volume":"38","author":"MS Toledo","year":"1999","unstructured":"Toledo MS, Levery SB, Straus AH, Suzuki E, Momany M, Glushka J, Moulton JM, Takahashi HK: Characterization of sphingolipids from mycopathogens: Factors correlating with expression of 2-hydroxy fatty acyl (E)-\u03943-unsaturation in cerebrosides of Paracoccidioides brasiliensis and Aspergillus fumigatus. Biochemistry. 1999, 38: 7294-7306. 10.1021\/bi982898z.","journal-title":"Biochemistry"},{"key":"1003_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1006\/bbrc.2000.4091","volume":"280","author":"MS Toledo","year":"2001","unstructured":"Toledo MS, Levery SB, Glushka J, Straus AH, Takahashi HK: Structure elucidation of sphingolipids from the Sporothrix schenckii: Identification of novel glycosylinositol phosphorylceramides with core Man\u03b11\u21926Ins linkage. Biochem Biophys Res Commun. 2001, 280: 19-24. 10.1006\/bbrc.2000.4091.","journal-title":"Biochem Biophys Res Commun"},{"key":"1003_CR23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S0014-5793(01)02275-X","volume":"493","author":"MS Toledo","year":"2001","unstructured":"Toledo MS, Levery SB, Straus AH, Takahashi HK: Sphingolipids of the mycophatogen Sporothrix schenckii : identification of a glycosylinositol phosphorylceramide with novel core GlcNH2\u03b11\u21922Ins motif. FEBS Letters. 2001, 493: 50-56. 10.1016\/S0014-5793(01)02275-X.","journal-title":"FEBS Letters"},{"key":"1003_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/glycob\/11.2.105","volume":"11","author":"MS Toledo","year":"2001","unstructured":"Toledo MS, Suzuki E, Levery SB, Straus AH, Takahashi HK: Characterization of monoclonal antibody MEST-2 specific to glucosylceramide of fungi and plants. Glycobiology. 2001, 11: 105-112. 10.1093\/glycob\/11.2.105.","journal-title":"Glycobiology"},{"key":"1003_CR25","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0005-2760(83)90138-8","volume":"754","author":"G Kawai","year":"1983","unstructured":"Kawai G, Ikeda Y: Chemistry and functional moiety of a fruiting-inducing cerebroside in Schizophyllum commune. Biochim Biophys Acta. 1983, 754: 243-248.","journal-title":"Biochim Biophys Acta"},{"key":"1003_CR26","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0022-2275(20)34376-5","volume":"26","author":"G Kawai","year":"1985","unstructured":"Kawai G, Ikeda Y: Structure of biologically active and inactive cerebrosides prepared from Schizophyllum commune. J Lipid Res. 1985, 26: 338-343.","journal-title":"J Lipid Res"},{"key":"1003_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0005-2760(89)90146-X","volume":"1001","author":"G Kawai","year":"1989","unstructured":"Kawai G: Molecular species of cerebrosides in fruiting bodies of Lentinus edodes and their biological activity. Biochim Biophys Acta. 1989, 1001: 185-190.","journal-title":"Biochim Biophys Acta"},{"key":"1003_CR28","doi-asserted-by":"publisher","first-page":"7049","DOI":"10.1128\/IAI.68.12.7049-7060.2000","volume":"68","author":"ML Rodrigues","year":"2000","unstructured":"Rodrigues ML, Travassos L, Miranda KR, Franzen AJ, Rozental S, Souza W, Alviano CS, Barreto-Bergter E: Human antibodies against a purified glucosylceramide from Cryptococcus neoformans inhibit cell budding and fungal growth. Infec Immun. 2000, 68: 7049-7060. 10.1128\/IAI.68.12.7049-7060.2000.","journal-title":"Infec Immun"},{"key":"1003_CR29","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1073\/pnas.97.7.3254","volume":"97","author":"M Bagnat","year":"2000","unstructured":"Bagnat M, Ker\u00e4nen S, Shevchenko A, Shevchenko A, Simons K: Lipid rafts function in biosynthetic delivery of proteins to the cell surface in yeast. Proc Natl Acad Sci USA. 2000, 97: 3254-3259. 10.1073\/pnas.060034697.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1003_CR30","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1128\/EC.5.3.488-498.2006","volume":"5","author":"AR Siafakas","year":"2006","unstructured":"Siafakas AR, Wright LC, Sorrell TC, Djordjevic JT: Lipid rafts in Cryptococcus neoformans concentrate the virulence determinants phospholipase B1 and Cu\/Zn superoxide dismutase. Eukaryot Cell. 2006, 5: 488-498. 10.1128\/EC.5.3.488-498.2006.","journal-title":"Eukaryot Cell"},{"key":"1003_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s004380000285","volume":"264","author":"H Terashima","year":"2000","unstructured":"Terashima H, Yabuki N, Arisawa M, Hamada K, Kitada K: Up-regulation of genes encoding glycosylphosphatidylinositol (GPI)-attached proteins in response to cell wall damage caused by disruption of FKS1 in Saccharomyces cerevisiae. Mol Gen Genet. 2000, 264: 64-74. 10.1007\/s004380000285.","journal-title":"Mol Gen Genet"},{"key":"1003_CR32","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1006\/bbrc.1996.0796","volume":"222","author":"SB Levery","year":"1996","unstructured":"Levery SB, Toledo MS, Suzuki E, Salyan ME, Hakomori S, Straus AH, Takahashi HK: Structural characterization of a new galactofuranose-containing glycolipid antigen of Paracoccidioides brasiliensis. Biochem Biophys Res Commun. 1996, 222: 639-645. 10.1006\/bbrc.1996.0796.","journal-title":"Biochem Biophys Res Commun"},{"key":"1003_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/glycob\/11.2.113","volume":"11","author":"MS Toledo","year":"2001","unstructured":"Toledo MS, Levery SB, Suzuki E, Straus AH, Takahashi HK: Characterization of cerebrosides from the thermally dimorphic mycopathogen Histoplasma capsulatum : expression of 2-hydroxy fatty N-acyl (E)-Delta(3)-unsaturation correlates with the yeast-mycelium phase transition. Glycobiology. 2001, 11: 113-124. 10.1093\/glycob\/11.2.113.","journal-title":"Glycobiology"},{"key":"1003_CR34","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0022-2275(20)39374-3","volume":"13","author":"RK Yu","year":"1972","unstructured":"Yu RK, Ledeen RW: Gangliosides of human, bovine, and rabbit plasma. J Lipid Res. 1972, 13: 680-686.","journal-title":"J Lipid Res"},{"key":"1003_CR35","doi-asserted-by":"crossref","first-page":"13723","DOI":"10.1016\/S0021-9258(18)86917-4","volume":"268","author":"AH Straus","year":"1993","unstructured":"Straus AH, Levery SB, Jasiulionis MG, Salyan ME, Steele SJ, Travassos LR, Hakomori S, Takahashi HK: Stage-specific glycosphingolipids from amastigote forms of Leishmania (L.) amazonensis. Immunogenicity and role in parasite binding and invasion of macrophages. J Biol Chem. 1993, 268: 13723-13730.","journal-title":"J Biol Chem"},{"key":"1003_CR36","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1590\/S0100-879X1997000300014","volume":"30","author":"AH Straus","year":"1997","unstructured":"Straus AH, Valero VB, Takizawa CM, Levery SB, Toledo MS, Suzuki E, Salyan ME, Hakomori S, Barbieri CL, Takahashi HK: Glycosphingolipid antigens from Leishmania (L.) amazonensis amastigotes. Binding of anti-glycosphingolipid monoclonal antibodies in vitro and in vivo. Braz J Med Biol Res. 1997, 30: 395-399. 10.1590\/S0100-879X1997000300014.","journal-title":"Braz J Med Biol Res"},{"key":"1003_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0003-2697(92)90167-6","volume":"201","author":"AH Straus","year":"1992","unstructured":"Straus AH, Travassos LR, Takahashi HK: ST-1 a monoclonal antibody specific for intact heparin. Anal Biochem. 1992, 201: 1-8. 10.1016\/0003-2697(92)90167-6.","journal-title":"Anal Biochem"},{"key":"1003_CR38","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/0003-2697(80)90667-3","volume":"109","author":"JL Magnani","year":"1980","unstructured":"Magnani JL, Smith DF, Ginsburg V: Detection of gangliosides that bind toxin: direct binding of 125I-labeled toxin to thin-layer chromatography. Anal Biochem. 1980, 109: 399-402. 10.1016\/0003-2697(80)90667-3.","journal-title":"Anal Biochem"},{"key":"1003_CR39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/00004770-200102000-00012","volume":"27","author":"ML Zuolo","year":"2001","unstructured":"Zuolo ML, Toledo MS, Nogueira HE, Straus AH, Takahashi HK: Identification of GM3 as a marker of therapy-resistant periradicular lesions. J Endodon. 2001, 27: 107-109. 10.1097\/00004770-200102000-00012.","journal-title":"J Endodon"},{"key":"1003_CR40","first-page":"4361","volume":"48","author":"HK Takahashi","year":"1988","unstructured":"Takahashi HK, Metoki R, Hakomori S: Immunoglobulin G3 monoclonal antibody directed to Tn antigen (tumor-associated alpha-N-acetylgalactosaminyl epitope) that does not cross-react with blood group A antigen. Cancer Res. 1988, 48: 4361-4367.","journal-title":"Cancer Res"},{"key":"1003_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1476-0711-8-13","volume":"8","author":"LS Derengowski","year":"2009","unstructured":"Derengowski LS, De-Souza-Silva C, Braz SV, Mello-De-Sousa TM, B\u00e1o SN, Kyaw CM, Silva-Pereira I: Antimicrobial effect of farnesol, a Candida albicans quorum sensing molecule, on Paracoccidioides brasiliensis growth and morphogenesis. Ann Clin Microbiol Antimicrob. 2009, 8: 13-10.1186\/1476-0711-8-13.","journal-title":"Ann Clin Microbiol Antimicrob"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2180-10-47.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T08:29:23Z","timestamp":1630484963000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/1471-2180-10-47"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,15]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1003"],"URL":"https:\/\/doi.org\/10.1186\/1471-2180-10-47","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,15]]},"assertion":[{"value":"15 June 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"47"}}